Skip to main content
Clinical Trials/NCT05280236
NCT05280236
Completed
Not Applicable

Comparison of Quality of Recovery Between Remimazolam and Propofol Anesthesia in Patients Undergoing Arthroscopic Meniscectomy

Yonsei University1 site in 1 country80 target enrollmentMarch 14, 2022

Overview

Phase
Not Applicable
Intervention
Propofol TIVA
Conditions
Adult Patients 19 or Older Scheduled for Elective Arthroscopic Meniscectomy
Sponsor
Yonsei University
Enrollment
80
Locations
1
Primary Endpoint
Quality of Recovery (QoR)-40 questionnaire
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study aims to compare quality of recovery after surgery and anesthesia between patients undergoing arthroscopic meniscectomy under general anesthesia with either propofol or remimazolam based total intravenous anesthesia. This study is a randomized trial with a 50% probability of being assigned to either group. Randomization will be done by an anesthesiologist not involved in anesthesia or postoperative outcome assessment. Patients and the investigator in charge of postoperative outcomes assessment will be blinded to group allocation.

Registry
clinicaltrials.gov
Start Date
March 14, 2022
End Date
April 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients 19 or older, ASA class I\~III,
  • scheduled for arthroscopic meniscectomy under general anesthesia and eligible for LMA use.

Exclusion Criteria

  • Patient refusal,
  • patients unable to read consent form, active URI or uncontrolled asthma,
  • pneumonia,
  • history of allergies to propofol or benzodiazepines,
  • decreased liver or kidney function, heart failure of ejection fraction\<55%,
  • pregnant or breastfeeding patients,
  • history of substance abuse/addiction

Arms & Interventions

Propofol

Patients receiving general anesthesia with propofol-based total intravenous anesthesia

Intervention: Propofol TIVA

Remimazolam

Patients receiving general anesthesia with remimazolam-based total intravenous anesthesia

Intervention: Remimazolam TIVA

Outcomes

Primary Outcomes

Quality of Recovery (QoR)-40 questionnaire

Time Frame: Postoperative 24 hours

Quality of recovery assessed with the QoR-40 questionnaire, which is a widely-used, self-rated, self-completed questionnaire for postoperative patients.

Study Sites (1)

Loading locations...

Similar Trials